TECX

Tectonic Therapeutic, Inc.

NasdaqHealthcareBiological Products, (No Diagnostic Substances)

Insider activity for last month from 08/09 to 09/09. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 08, 2026Most recent Form 4
Total buying$00 buys
Total selling$157k1 sells
Net open-market-$157k5 insiders
Open-market mix
Buy vs sell distribution by transaction count
1 transactions
0 buys0%·100%1 sells

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
530-3-5transactionsAug 2026 sells: 1 transactions · $157k1AugSep

Transaction codes

By Form 4 transaction code in selected period
8transactions
  • A · Grants / awards · dominant5 · 63%
  • M · Option exercise2 · 25%
  • S · Open-market sells1 · 13%

Activity by reported role

A joint filing can contribute to multiple roles
8transactions
  • CSO · dominant4 · 50%
  • CBO1 · 13%
  • Chief executive officer1 · 13%
  • Chief financial officer1 · 13%
  • CMO1 · 13%

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (5)
Aug 2026Sep 2026
6distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
McNamara PeterCommon Stock · Direct
55.3k55.3kAug 25, 2026 · 55,328 shares owned afterAug 25, 2026 · 55,285 shares owned afterAug 25, 2026Aug 25, 2026
55,285Aug 25, 2026
McNamara PeterEmployee Stock Option (Right to Buy) · Direct
21.0k7.8kAug 25, 2026 · 7,787 shares owned afterSep 03, 2026 · 21,000 shares owned afterAug 25, 2026Sep 03, 2026
21,000Sep 03, 2026
Reicin AliseEmployee Stock Option (Right to Buy) · Direct
69.3k69.3kSep 03, 2026 · 69,250 shares owned afterSep 03, 2026Sep 03, 2026
69,250Sep 03, 2026
Ruddy Marcella K.Employee Stock Option (Right to Buy) · Direct
24.3k24.3kSep 03, 2026 · 24,250 shares owned afterSep 03, 2026Sep 03, 2026
24,250Sep 03, 2026
Lochner DanielEmployee Stock Option (Right to Buy) · Direct
24.3k24.3kSep 03, 2026 · 24,250 shares owned afterSep 03, 2026Sep 03, 2026
24,250Sep 03, 2026
Schwabish MarcEmployee Stock Option (Right to Buy) · Direct
17.8k17.8kSep 03, 2026 · 17,750 shares owned afterSep 03, 2026Sep 03, 2026
17,750Sep 03, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 09Sep 09
LessMore
Top insiders
By absolute net value across the selected period
1 insiders
  • MP
    McNamara PeterCSO · rank 1 · 0 buys · 1 sells
    -$1.6klast 08/26/undefined
Recent filing activity
Most recent 1 transactions · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$157k
10b5-1 detected3
Amended rows0

Filing-only signals

Deterministic matches in the selected period

TECX transaction history

Filters apply within this company and selected period by default
Reset
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TECXMcNamara Peter
CSO
sale10b5-143-$157kS08/2608/25

Tectonic Therapeutic, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Tectonic Therapeutic, Inc.?

Schwabish Marc, McNamara Peter, Lochner Daniel, Ruddy Marcella K., REICIN ALISE.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

McNamara Peter reported a sale on Aug 25, 2026 valued at $157k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $1,570.36. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.